|
Status |
Public on Nov 01, 2017 |
Title |
SUDHL-4 100nM CPI203 6h |
Sample type |
RNA |
|
|
Source name |
SUDHL-4 100nM CPI203
|
Organism |
Homo sapiens |
Characteristics |
cell line: DHL cell line SUDHL-4 agent: CPI203
|
Treatment protocol |
DHL cells were treated with 100 nM CPI203 for 6h
|
Growth protocol |
DHL cells at exponential phase were set at 1x10^6 cells/ml for the experiment
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using the Trizol reagent
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 150 ng total RNA
|
|
|
Hybridization protocol |
RNA samples were processed to Affymetrix GeneChip HT HG-U219 arrays.
|
Scan protocol |
Scanning was processed in the Gene Titan instrument.
|
Description |
Double Hit Lymphoma cell line
|
Data processing |
Determination of the signal value for each probe set of the array were obtained with GeneChip® Command Console® Software (AGCC) (Affymetrix). Raw data were normalized using the Robust Multichip Analysis (RMA) algorithm implemented in the Expression Console Software v1.1 (Affymetrix).
|
|
|
Submission date |
May 15, 2017 |
Last update date |
Jan 23, 2018 |
Contact name |
Juan Garcia Valero |
E-mail(s) |
[email protected]
|
Organization name |
IDIBAPS
|
Department |
Oncology and haematology
|
Lab |
Physiopathology and molecular bases in hematology
|
Street address |
Rosselló, 153
|
City |
Barcelona |
State/province |
Barcelona |
ZIP/Postal code |
08036 |
Country |
Spain |
|
|
Platform ID |
GPL13667 |
Series (1) |
GSE98905 |
The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma |
|